Pale Fire Capital Se Portfolio Holdings

Pale Fire Capital Se

  • $638 Billion
  • Q3 2024

Pale Fire Capital Se has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $638 Billion distributed in 54 stocks.

Among their holdings, we can observe that their the top five positions include companies like: At&T Inc. with a value of $211B, Dole PLC with a value of $107B, Groupon, Inc. with a value of $99.6B, B2 Gold Corp with a value of $52.9B, and International Seaways, Inc. with a value of $38.9B.

Examining the 13F form we can see an decrease of $249B in the current position value, from $887B to 638B.

Pale Fire Capital Se is based out at Prague, 2N

Below you can find more details about Pale Fire Capital Se portfolio as well as his latest detailed transactions.

Portfolio value $638 Billion
Communication Services: $331 Billion
Consumer Defensive: $107 Billion
Basic Materials: $68.9 Billion
Energy: $57.5 Billion
Healthcare: $31.4 Billion
Industrials: $10.8 Billion
Real Estate: $2.85 Billion
Consumer Cyclical: $1.24 Billion
Other: $373 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$163B
$211 Billion 33.13% of portfolio
9,603,558
Q3 2024 Reduced 8.39%
$1.36B
$107 Billion 16.73% of portfolio
6,547,483
Q3 2024 Reduced 20.12%
$343M
$99.6 Billion 15.61% of portfolio
10,181,070
Q1 2024 Added 44.61%
$2.78B
$52.9 Billion 8.3% of portfolio
17,186,079
Q3 2024 Reduced 11.08%
$1.66B
$38.9 Billion 6.1% of portfolio
754,415
Q3 2024 Reduced 21.2%
$1.63B
$18.8 Billion 2.95% of portfolio
2,047,323
Q3 2024 Added 91.87%
$1.32B
$15.9 Billion 2.49% of portfolio
2,216,410
Q3 2024 Reduced 22.24%
$141M
$13.9 Billion 2.18% of portfolio
5,395,100
Q3 2024 Reduced 15.86%
$715M
$12.7 Billion 1.99% of portfolio
504,398
Q3 2024 Reduced 0.55%
$0
$11.5 Billion 1.8% of portfolio
9,889,569
Q3 2024 Added 2,378.28%
$1.32B
$10.7 Billion 1.67% of portfolio
170,226
Q3 2024 Reduced 75.31%
Chimera Invt Corp
-
$5.37 Billion 0.84% of portfolio
-
Q3 2024 New
Praxis Precision Medicines I
-
$3.87 Billion 0.61% of portfolio
-
Q3 2024 New
$691M
$3.81 Billion 0.6% of portfolio
438,200
Q3 2024 New
$1.13B
$3.39 Billion 0.53% of portfolio
95,810
Q3 2024 New
$2.8B
$3.23 Billion 0.51% of portfolio
45,310
Q3 2024 Reduced 87.36%
$221B
$2.7 Billion 0.42% of portfolio
40,925
Q3 2024 Reduced 98.15%
Adverum Biotechnologies Inc
-
$2.16 Billion 0.34% of portfolio
-
Q3 2024 New
$586M
$1.85 Billion 0.29% of portfolio
442,298
Q3 2024 Reduced 31.14%
Mineralys Therapeutics Inc
-
$1.66 Billion 0.26% of portfolio
-
Q3 2024 Added 292.39%
$813M
$1.66 Billion 0.26% of portfolio
336,468
Q3 2024 Added 412.91%
$116M
$1.44 Billion 0.23% of portfolio
734,904
Q3 2024 Added 1,779.21%
New York Mtg Tr Inc
-
$1.32 Billion 0.21% of portfolio
-
Q3 2024 New
$1.12B
$1.24 Billion 0.19% of portfolio
99,938
Q3 2024 New
$48.1M
$1.07 Billion 0.17% of portfolio
1,602,792
Q3 2024 Added 805.37%
$163M
$1 Billion 0.16% of portfolio
133,271
Q3 2024 New
$26.1M
$1.03 Billion 0.16% of portfolio
510,724
Q3 2024 Added 3,078.12%
$121M
$986 Million 0.15% of portfolio
188,537
Q3 2024 Added 384.66%
$2B
$373 Million 0.06% of portfolio
59,289
Q3 2024 Added 236.47%
$1.24B
$351 Million 0.06% of portfolio
37,375
Q3 2024 Added 154.25%
Disc Medicine Inc
-
$325 Million 0.05% of portfolio
-
Q3 2024 New
$95.9M
$230 Million 0.04% of portfolio
52,985
Q3 2024 Added 35.86%
$554M
$279 Million 0.04% of portfolio
24,462
Q3 2024 Added 112.27%
Biohaven LTD
-
$275 Million 0.04% of portfolio
-
Q3 2024 New
Creative Media & Cmnty Tr
-
$239 Million 0.04% of portfolio
-
Q3 2024 Added 11.69%
$188M
$260 Million 0.04% of portfolio
17,458
Q3 2024 Added 49.82%
$255M
$237 Million 0.04% of portfolio
254,963
Q3 2024 Added 53.4%
$57M
$218 Million 0.03% of portfolio
43,723
Q3 2024 Added 102.67%
$324M
$221 Million 0.03% of portfolio
45,600
Q3 2024 New
$2.07B
$205 Million 0.03% of portfolio
7,686
Q3 2024 New
$191M
$212 Million 0.03% of portfolio
32,309
Q3 2024 Added 126.06%
$203M
$120 Million 0.02% of portfolio
24,000
Q3 2024 New
Achieve Life Sciences Inc
-
$157 Million 0.02% of portfolio
-
Q3 2024 New
Syros Pharmaceuticals Inc
-
$106 Million 0.02% of portfolio
-
Q3 2024 New
$172M
$118 Million 0.02% of portfolio
24,289
Q3 2024 New
$36.2M
$50 Million 0.01% of portfolio
22,026
Q3 2024 New
Cellectar Biosciences Inc
-
$53.6 Million 0.01% of portfolio
-
Q3 2024 New
$41.8M
$49.2 Million 0.01% of portfolio
10,500
Q3 2024 New
$130M
$51.7 Million 0.01% of portfolio
24,291
Q3 2024 Reduced 30.72%

Summary

  • Portfolio
  • No. of Stocks 54
  • Current Value $638 Billion
  • Prior Value $887 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 21 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email